Pharmafile - Manufacturing and Production News
Manufacturing investment gives company lead on rivals
Site in Oss will also boost its biologics capability
German facility deal marks end of Pfizer's inhaled insulin ambitions
New facility updates from KV Pharma, Cargill, Gerresheimer, Asymchem Labs, CoreRx and Anu's Labs
Companies will develop and market a portfolio of follow-on biologics
French vaccine facility should start production in 2013